160 related articles for article (PubMed ID: 12086267)
1. Genetics of ANCA-associated vasculitides.
Kallenberg CG; Rarok A; Stegeman CA
Cleve Clin J Med; 2002; 69 Suppl 2():SII61-3. PubMed ID: 12086267
[No Abstract] [Full Text] [Related]
2. Gene structure of ANCA target antigens: implications for the pathogenesis of vasculitis.
Jenne DE
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):209-13. PubMed ID: 8946583
[No Abstract] [Full Text] [Related]
3. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele.
Griffith ME; Lovegrove JU; Gaskin G; Whitehouse DB; Pusey CD
Nephrol Dial Transplant; 1996 Mar; 11(3):438-43. PubMed ID: 8671812
[TBL] [Abstract][Full Text] [Related]
4. L31. A GWAS in ANCA-associated vasculitis: will genetics help re-define clinical classification?
Lyons PA; Smith KG
Presse Med; 2013 Apr; 42(4 Pt 2):589-91. PubMed ID: 23490642
[No Abstract] [Full Text] [Related]
5. Genetic impact of pathogenesis and prognosis of ANCA-associated vasculitides.
Borgmann S; Haubitz M
Clin Exp Rheumatol; 2004; 22(6 Suppl 36):S79-86. PubMed ID: 15675141
[TBL] [Abstract][Full Text] [Related]
6. [New insights into the pathogenesis of ANCA-positive vasculitides].
Guilpain P; Guillevin L; Mouthon L
Presse Med; 2007 May; 36(5 Pt 2):854-9. PubMed ID: 17350787
[TBL] [Abstract][Full Text] [Related]
7. ANCA--pathophysiology revisited.
Kallenberg CG; Brouwer E; Mulder AH; Stegeman CA; Weening JJ; Tervaert JW
Clin Exp Immunol; 1995 Apr; 100(1):1-3. PubMed ID: 7697907
[No Abstract] [Full Text] [Related]
8. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes.
Tervaert JW; Mulder AH; Kallenberg CG
Adv Exp Med Biol; 1993; 336():253-6. PubMed ID: 8296614
[TBL] [Abstract][Full Text] [Related]
10. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
[TBL] [Abstract][Full Text] [Related]
11. [New aspects in ANCA-associated vasculitides].
Lamprecht P
Med Klin (Munich); 2004 Sep; 99(9):518-22. PubMed ID: 15372181
[TBL] [Abstract][Full Text] [Related]
12. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
[TBL] [Abstract][Full Text] [Related]
13. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
14. Proteinase 3: substrate specificity and possible pathogenetic effect of Wegener's granulomatosis autoantibodies (c-ANCA) by dysregulation of the enzyme.
Dolman KM; van de Wiel BA; Kam CM; Kerrigan JE; Hack CE; von dem Borne AE; Powers JC; Goldschmeding R
Adv Exp Med Biol; 1993; 336():55-60. PubMed ID: 8296674
[TBL] [Abstract][Full Text] [Related]
15. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases.
Hauschild S; Schmitt WH; Csernok E; Flesch BK; Rautmann A; Gross WL
Adv Exp Med Biol; 1993; 336():245-51. PubMed ID: 8296613
[TBL] [Abstract][Full Text] [Related]
16. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Wegener's granulomatosis with intravenous immunoglobulin.
Richter C; Schnabel A; Csernok E; Reinhold-Keller E; Gross WL
Adv Exp Med Biol; 1993; 336():487-9. PubMed ID: 8296662
[TBL] [Abstract][Full Text] [Related]
18. HLA genes in ANCA-associated vasculitides.
Griffith ME; Pusey CD
Exp Clin Immunogenet; 1997; 14(3):196-205. PubMed ID: 9493788
[TBL] [Abstract][Full Text] [Related]
19. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
[TBL] [Abstract][Full Text] [Related]
20. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
